Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood-brain barrier dysfunction and recovery.

A G de Boer1, P J Gaillard

  • 1Blood-Brain Barrier Research Group, Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, University of Leiden, Gorlaeus Laboratories, Leiden, The Netherlands. B.Boer@LACDR.LeidenUniv.NL

Journal of Neural Transmission (Vienna, Austria : 1996)
|March 22, 2006
PubMed
Summary

The blood-brain barrier (BBB) protects the brain, but diseases increase its permeability. N-acetylcysteine and glucocorticoids were found to protect the BBB from inflammatory damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.

British journal of clinical pharmacology·2018
Same author

A SpoT polymorphism correlates with chill stress survival and is prevalent in clinical isolates of Campylobacter jejuni.

Poultry science·2014
Same author

Comparative population structure analysis of Campylobacter jejuni from human and poultry origin in Bangladesh.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same author

Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

Pharmaceutical research·2013
Same author

Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

Pharmaceutical research·2013
Same author

A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2012

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • The blood-brain barrier (BBB) is a critical interface regulating molecular exchange between blood and the brain.
  • Neurological diseases often compromise BBB integrity, leading to increased permeability.
  • Understanding signal transduction pathways affected by inflammation is crucial for BBB protection.

Purpose of the Study:

  • To investigate signal transduction routes influenced by inflammatory stimuli at the BBB.
  • To evaluate the protective effects of N-acetylcysteine and glucocorticoids on BBB integrity.
  • To assess the impact of glucocorticoids and interferon-alpha,beta on BBB tightness.

Main Methods:

  • Studied signal transduction pathways affected by inflammatory stimuli.

Related Experiment Videos

  • Administered N-acetylcysteine to assess its protective effects on the BBB.
  • Applied glucocorticoids and interferon-alpha,beta in an in vitro BBB model.

    • Main Results:

    • N-acetylcysteine demonstrated protection of the BBB against inflammatory stimuli.
    • Glucocorticoids also showed protective effects on BBB integrity.
    • Glucocorticoids and interferon-alpha,beta enhanced BBB tightness in vitro, with a potentiating effect when combined.

    Conclusions:

    • The BBB's integrity is frequently compromised in brain diseases.
    • N-acetylcysteine and glucocorticoids show promise in protecting the BBB from inflammatory damage.
    • Combined administration of glucocorticoids and interferon-alpha,beta may enhance BBB tightness.